The U.S. Department of Health and Human Services (HHS) Office of the Deputy Secretary has issued a Request for Information (RFI) seeking input on what HHS can do to accelerate the responsible adoption and use of artificial intelligence (AI) in clinical care.
As the nation’s principal health regulator and a major payer, HHS plays a significant role in shaping how AI technologies are developed, evaluated, reimbursed, and deployed across the health care system. Through this survey, the American Academy of Orthotists and Prosthetists is gathering input from its members to inform a consolidated response on behalf of the profession.
Regulatory Considerations
HHS seeks to establish a regulatory approach to AI that is clear, predictable, and proportionate to risk—one that supports innovation while protecting patient safety, data privacy, and public trust.
Reimbursement and Payment Policy Considerations
Payment policies strongly influence whether and how innovations are adopted in clinical care. Legacy fee-for-service systems may create challenges for integrating new technologies, including AI-enabled tools. HHS is seeking feedback on how reimbursement models might be modernized to better align with value, innovation, and patient outcomes.
The following questions are intended to capture your experiences, observations, and perspectives related to AI in clinical care, including its opportunities, limitations, and implications for clinicians, patients, and caregivers.
